Evidence map›Paper›PMID 18185530›Full record

ArticleThe Journal of investigative dermatology2008

Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals.

Maryam M Asgari, Nancy B Kiviat, Cathy W Critchlow, Joshua E Stern, Zsolt B Argenyi, Gregory J Raugi, Daniel Berg, Peter B Odland, Stephen E Hawes, Ethel-Michele de Villiers

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. RNA-Sequencing Reveals Two Subgroups of Eccrine Porocarcinomas and Poromas.Journal of cellular and molecular medicine · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. NontyphoidalInternational journal of environmental research and public health · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Maryam M AsgariDivision of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA. Maryam.m.asgari@kp.org
Nancy B Kiviat
Cathy W Critchlow
Joshua E Stern
Zsolt B Argenyi
Gregory J Raugi
Daniel Berg
Peter B Odland
Stephen E Hawes
Ethel-Michele de Villiers
University of Washington · USGerman Cancer Research Center · DEKaiser Permanente · US

Funding

Epidemiology of HPV and p53 Mutations in NM Skin CancerR01CA084087 · NCI · UNIVERSITY OF WASHINGTON · PI KIVIAT, NANCY B. · 2001 to 2005
$2.7M
The role of HPV in squamous cell carcinomaF32AR047552 · NIAMS · UNIVERSITY OF WASHINGTON · PI ASGARI, MARYAM MANDANA · 2000 to 2002
$99k
NCI NIH HHS R01 CA084087NIAMS NIH HHS 1 F32 AR47552NIAMS NIH HHS F32 AR047552
6 · The paper itself

Abstract

The presence of certain types of human papillomavirus (HPV) is a known risk factor for the development of anogenital squamous cell carcinomas (SCCs). A similar association has been hypothesized for cutaneous SCCs, although, to our knowledge, no studies to date have combined sensitive HPV DNA detection techniques with epidemiologic data controlling for known risk factors to explore the association. We designed a case-control study examining HPV prevalence using highly sensitive PCR-detection assays in tissue samples from 85 immunocompetent patients with histologically confirmed SCCs and 95 age-matched individuals without a prior history of skin cancer. A standardized interview was administered to all study subjects to collect information pertaining to potential confounding variables. The overall detection rate of HPV DNA was high in case lesions (54%) and perilesions (50%) and in both sun-exposed normal tissue (59%) and non-sun-exposed normal tissue (49%) from controls. In comparing case tissue to control tissue, there was no differential detection of HPV DNA across various HPV species. However, HPV DNA from beta-papillomavirus species 2 was more likely to be identified in tumors than in adjacent healthy tissue among cases (paired analysis, odds ratio=4.0, confidence interval=1.3-12.0). The high prevalence of HPV DNA detected among controls suggests that HPV DNA is widely distributed among the general population. However, the differential detection of HPV beta-papillomavirus species in tumors among cases suggests that certain HPV types may be involved in the progression of cutaneous SCCs.

Indexed as

DNA, ViralAgedCarcinoma, Squamous CellCase-Control StudiesFemaleHumansMaleMiddle AgedOdds RatioPapillomaviridaePhylogenyRisk FactorsSkinSkin NeoplasmsUltraviolet RaysDNA, Viral

Identifiers

PMID18185530
PMCPMC3268673
OpenAlexW2151748492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.